GLP-1 · Semaglutide · AustraliaWegovy vs Ozempic in Australia:
Same Active Ingredient, Two Very Different Prescriptions
Both contain semaglutide. Both are weekly injections. But in Australia, the difference between Wegovy and Ozempic at the pharmacy counter is enormous, here's what you actually need to know.
Keep every weekly injection, dose change and repeat in one place, 30-day trial, then a subscription.
Already prescribed? Track your injection day, dose and repeats. MediRemind.
The key differences, at a glance
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Approved use (Australia) | Type 2 diabetes management | Chronic weight management |
| PBS-listed? | Yes, for eligible diabetes patients | No, self-funded (private cost) |
| Maximum dose | 1 mg/week in Australia | 2.4 mg/week |
| Dose escalation | 4-weekly, shorter schedule | 16 weeks to reach maintenance |
| Injection frequency | Once weekly | Once weekly |
| Approximate monthly cost* | Up to $25.00 (general) or $7.70 (concession), PBS eligible T2D patients only | ~$250–$460 (private, not PBS-listed) |
| Supply situation | Ongoing shortages reported | Newer to market in AU |
*Approximate costs only. Always confirm current pricing with your pharmacy and GP.
The PBS gap, and why it matters so much
The biggest practical difference between these two medications in Australia isn't the dose. It's whether Medicare helps you pay for it.
Ozempic is listed on the Pharmaceutical Benefits Scheme (PBS) for Australians with a type 2 diabetes diagnosis. Eligible patients pay the standard PBS co-payment, up to $25.00 per month (general patient) or $7.70 (concession card holder), subject to PBS eligibility and any applicable premiums. That's a manageable ongoing cost for most people.
Wegovy is approved by the TGA for weight management, but it is not PBS-listed for that purpose. Most patients pay the full private price, approximately $250–$460 per month, depending on dose and pharmacy. Novo Nordisk's listing documentation is marked Not Accepted as of 1 October 2026; no listing date has been announced. That makes staying on schedule and tracking repeats significantly more important.
Dose escalation: Wegovy takes longer
Both medications require gradual dose increases. Wegovy's full escalation takes 16 weeks to reach the maintenance dose of 2.4 mg:
Wegovy dose escalation schedule
In Australia, Ozempic follows a shorter escalation: 0.25 mg → 0.5 mg → 1 mg. MediRemind lets you record your current prescribed dose and set a reminder for the schedule you enter.
GLP-1 price comparison: Wegovy vs Ozempic vs Mounjaro in Australia (2026)
For Australians choosing between or managing these three medications, cost is often the deciding factor, and the difference between them is enormous depending on your PBS eligibility.
| Ozempic | Wegovy | Mounjaro | |
|---|---|---|---|
| Active ingredient | Semaglutide | Semaglutide | Tirzepatide |
| PBS-listed (2026)? | Yes, for eligible T2D patients | No, private prescription only | No, not PBS-listed for any use |
| PBS co-payment (if eligible)* | Up to $25.00 (general) / $7.70 (concession) | N/A, not PBS-listed | Not PBS-listed for any use |
| Private price | Varies by pen and pharmacy | ~$250–$460 per four-week pen | ~$280–$690 per four-dose KwikPen |
| Weight management subsidy | Not PBS-subsidised | Not PBS-subsidised (October 2026) | Not PBS-listed for any use |
| Weekly injection? | Yes | Yes | Yes |
*PBS co-payments as at 2026. General patient / concession card holder rates. Confirm current prices with your pharmacy.
The PBS gap is the single biggest cost variable for Australians on GLP-1 therapy. Ozempic for eligible type 2 diabetes patients costs $25.00/month on the PBS. Wegovy is not PBS-listed for weight management, and all patients pay private rates of approximately $250–$460/month regardless of their Medicare or concession status. Novo Nordisk's listing documentation is marked Not Accepted as of 1 October 2026, and no listing date has been announced.
Mounjaro sits at the expensive end. It is not PBS-listed. PBS status records show different stages for separate tirzepatide submissions; no listing is shown. Published pharmacy examples checked 1 October 2026 ranged from $279.99 to $689.99 for a four-week KwikPen. See the full Mounjaro dose-price guide →
Private prices for all three medications vary significantly between pharmacies and by dose strength. The figures above are indicative mid-range estimates for 2026; your actual cost may be higher or lower. It's always worth ringing ahead to compare dispensing prices, particularly for Mounjaro and private Wegovy where there is no price cap.
For all three, but especially for Wegovy and Mounjaro where you're funding the treatment yourself, having a system matters. Losing track of injection dates, remaining supply or repeat expiry can create unnecessary treatment delays and additional appointments. Weekly reminders, repeat tracking, and knowing exactly when your script runs out before it becomes a problem are the practical case for using MediRemind.
Prices vary between pharmacies, use the MediRemind PBS Cost Calculator to find your exact out-of-pocket cost for Ozempic, Wegovy, or Mounjaro.
Why tracking matters so much for both
Whether you're on Ozempic or Wegovy, losing track of your schedule matters. Missing or delaying an injection can disrupt the schedule prescribed by your healthcare professional. Always follow the missed-dose instructions provided with your medicine or contact your prescriber or pharmacist.
Remember which day you injected
It sounds simple until you can't remember whether Tuesday's injection happened or slipped to Wednesday. When you mark an injection as taken, MediRemind records the date so you can check your history later.
Know where you are in the escalation
Recording your current dose and setting a reminder for the next increase means you do not have to dig through old messages or rely on memory for something this important.
Plan ahead for each repeat
MediRemind stores your eScript or paper script, tracks remaining repeats, and notifies you before they are exhausted, so you can book your GP appointment with time to spare.
Frequently asked questions
Can I switch from Ozempic to Wegovy in Australia?
Only under your doctor's guidance. While both contain semaglutide, they have different approved indications and doses. Your GP will advise whether a switch is appropriate for your situation and whether your script needs to change.
If I'm on Ozempic for diabetes, can I get PBS pricing?
Yes, if you have a type 2 diabetes diagnosis and meet the eligibility criteria, Ozempic is PBS-listed. Your GP will prescribe it accordingly. Speak to your doctor about eligibility.
Ozempic is out of stock. Can I use Wegovy instead?
Not automatically, they are registered as separate medications with different indications in Australia. Your GP may consider alternatives based on your specific situation. Consult your doctor if you're affected by supply shortages.
Does MediRemind work for both Ozempic and Wegovy?
Yes. You can add either medication to your MediRemind profile, set your weekly injection reminder, record your current dose, track your dose escalation schedule, and store your repeat prescriptions, regardless of which medication you're on.
How do I find out exactly what my medication will cost?
Use the MediRemind PBS Cost Calculator at https://www.mediremind.com.au/pbs-medication-cost-calculator-australia. Enter your medication name and it shows you the current PBS co-payment, private prescription price, concession rate, and Safety Net threshold, all in one place.
Disclaimer: MediRemind is designed to support medication management and does not provide medical advice. Always follow your prescribing doctor's instructions regarding Wegovy or Ozempic dosing and any side effects you experience.
This article is for general information only and does not constitute medical or pharmaceutical advice. Information about PBS listings, TGA approvals and medication pricing is accurate at the time of writing and subject to change, verify current status at PBS.gov.au or TGA.gov.au before relying on it. Speak to your doctor or pharmacist before making any decisions about your medication or treatment. MediRemind is not affiliated with Novo Nordisk or any other pharmaceutical manufacturer.
References to weight management medications on this page are for general information only. MediRemind does not prescribe, supply or endorse any specific medication. Individual circumstances vary, speak to your doctor about which treatment is appropriate for you.
Ready to organise your next weekly injection?
Track your injection day, current dose, remaining supply and repeat prescriptions in one private Australian app.
Keep your injection schedule, prescribed dose and repeats organised with MediRemind. 30-day trial, then a subscription, $4.99/month or $39.99/year.